AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05948384 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: PNF
Description: For the PNF intervention, we applied a lower extremity hip extension-abduction-internal rotation with knee extension pattern, together with the rhythmic initiation of a repeated stretch and a combination of isotonic techniques. By this we'll target rectus femoris, medial gastrocnemius, lateral gastrocnemius, biceps femoris and semitendinosus musculature of the patient. The session will be given in 2 sets of 5 repetitions with rest of 45 seconds
Study NCT05948384 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: PNF
Description: For the PNF intervention, we applied a lower extremity hip extension-abduction-internal rotation with knee extension pattern, together with the rhythmic initiation of a repeated stretch and a combination of isotonic techniques. By this we'll target rectus femoris, medial gastrocnemius, lateral gastrocnemius, biceps femoris and semitendinosus musculature of the patient. The session will be given in 2 sets of 5 repetitions with rest of 45 seconds
Study NCT06450119 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: walking training
Description: The walking training alone group would receive walking training for 60 minutes twice weekly for twelve weeks.
Study NCT05335889 — intervention group
Intervention type: DEVICE
Intervention: eButton
Description: The eButton is a wearable camera that takes pictures every 6 seconds of whatever is in front of participants. The recorded data are processed by algorithms to determine food names, volumes, and nutrient value of the consumed food (e.g., grams of carbohydrates). The eButton is a wearable device containing a multicore microprocessor, a rechargeable battery capable of 10-15 hours of continuous operation (upon a flexible choice of battery capacity), a miniSD card for data storage.
Study NCT05335889 — intervention group
Intervention type: DEVICE
Intervention: Continuous Glucose Monitoring (CGM)
Description: The use of this device provides ambulatory glucose profiles, giving graphic and quantitative information on 24-hour glucose patterns. It does not require finger-prick testing for calibration. The system consists of a reader and a sensor (35 mm x 5 mm). The sensor is applied to the back of a person's arm. The sensor automatically measures interstitial glucose at 15-minute intervals during daily activities like work, sleep, eating, and exercise. It is able to store blocks of glucose data for 14 days.
Study NCT05072444 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: QPX7728
Description: beta lactamase inhibitor
Study NCT05072444 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: QPX2014
Description: antibiotic
Study NCT06248957 — intervention group
Intervention type: COMBINATION_PRODUCT
Intervention: Immunomodulation
Description: Variable protocols for combined immunomodulatory therapies currently in use for different forms of immune dysregulation
Study NCT06450119 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: walking training
Description: The walking training alone group would receive walking training for 60 minutes twice weekly for twelve weeks.
Study NCT06450119 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: cognition training
Description: The cognition training alone group would receive cognition training for 60 minutes twice weekly for twelve weeks.
Study NCT06450119 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: cognition training
Description: The cognition training alone group would receive cognition training for 60 minutes twice weekly for twelve weeks.
Study NCT05030714 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Visual Field Testing
Description: Visual field testing using the protocol 24-2 and/or 10-2 Threshold Test
Study NCT05148884 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NLX-112
Description: NLX-112 will be supplied as tablets containing 0.25 mg NLX-112. NLX-112 is a structurally novel centrally acting, high-efficacy selective 5-HT1A receptor agonist with nanomolar affinity for 5-HT1A receptors. Proposed as a treatment for L-DOPA-induced-dyskinesia in Parkinson's disease.
Study NCT05148884 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo will be matching tablets (identical weight, shape and color) without NLX-112.
Study NCT05188157 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: mirror therapy
Description: The patients in IG will receive exercise program before mirror theraphy. The patient will continue to do the exercises in front of the mirror for the remaining 20 minutes of the exercise. While doing the exercise with the healthy side in front of the mirror, the patient will try to do the same movement with the shoulder diagnosed with impingement syndrome on the other side of the mirror. The patient will try to do the movement correctly with the reflection in the mirror.
Study NCT05188157 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: conventional physiotherapy
Description: The conventional physiotherapy program included, wand exercises for shoulder abduction, flexion, hyperextension and internal and external rotation, Codman exercises and isometric and resistive exercises of the shoulder girdle. The exercise program is performed under the supervision of an experienced physiotherapist. The isometric exercises will be used during the painful period, and the resistance exercises will be added after the pain began to relieve.under the supervision of a physician in the first 30 minutes of their exercise.
Study NCT05188157 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: conventional physiotherapy
Description: The conventional physiotherapy program included, wand exercises for shoulder abduction, flexion, hyperextension and internal and external rotation, Codman exercises and isometric and resistive exercises of the shoulder girdle. The exercise program is performed under the supervision of an experienced physiotherapist. The isometric exercises will be used during the painful period, and the resistance exercises will be added after the pain began to relieve.under the supervision of a physician in the first 30 minutes of their exercise.
Study NCT05382000 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Advanced triage tool for Gynecology and Obstetrics emergencies based on artificial intelligence algorithms.
Description: After the conventional triage, a second independent doctor will make the suit with the Mediktor Hospital tool.. In less than 3 minutes and with an average of 14 questions, Mediktor performs an interrogation very similar to what an emergency doctor would do. The professional version allows the health professional to modify the course of the questions in the middle of the evaluation, if he considers it necessary to go deeper into some aspect of the anamnesis. The system allows you to see in real time the diseases that Mediktor considers possible during the evaluation.~At the end of the triage process, Mediktor offers the level of urgency and a list of possible diagnoses based on the signs and symptoms answered. The professional can change the level of urgency if he considers it beneficial for the patient.~Once the two triages (Conventional and Mediktor) have been carried out, the patient will be seen according to the care protocols of the center.
Study NCT06339476 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Serum ADMA, MDA and M30 levels mesurment
Description: Blood samples collected from patienst, only 7 mL
Study NCT05170776 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pilates and postural correction exercise
Description: ten exercises will be performed:~1. Hip Twist Level 1~2. Double leg stretch Level 1~3. Double leg stretch Level 2~4. One leg stretch Level 1~5. Clam Level 1~6. Scissors Level 1~7. Arm openings Level 1~8. Breast stroke prep Level 1t~9. Hip Twist Level 1.~10. Breast stroke prep Level 2 as for level 1 postural correction exercise~1-Strengthening deep cervical flexors 2-Stretching cervical extensors 3- Strengthen shoulder retractors 4-Unilateral and bilateral pectoralis stretch
Study NCT05170776 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Pilates exercises
Description: ten exercises will be performed:~1. Hip Twist Level 1~2. Double leg stretch Level 1~3. Double leg stretch Level 2~4. One leg stretch Level 1~5. Clam Level 1~6. Scissors Level 1~7. Arm openings Level 1~8. Breast stroke prep Level 1t~9. Hip Twist Level 1.~10. Breast stroke prep Level 2 as for level 1
Study NCT05170776 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: postural correction exercises
Description: postural correction exercise in the form of :~1. Strengthening deep cervical flexors through chin tucks,~2. Stretching cervical extensors through a chin drop~3. Strengthen shoulder retractors~4. Unilateral and bilateral pectoralis stretch alternating each two-week period.
Study NCT06078800 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: YL-17231
Description: After a screening period of approximately 14 days, eligible patients will receive oral YL-17231 once or twice daily until documented disease progression, unacceptable AEs, intercurrent illness preventing further administrations of study treatment, investigator's decision to withdrawal, the patient's consent of withdrawal, pregnancy, or for administrative reasons. Following the end of treatment, patients will continue to be followed for safety for 30 days. Patients who permanently discontinue study treatment for reasons other than disease progression will have post-treatment follow-up for disease assessment until start of new anticancer treatment, patient's consent of withdrawal, lost to follow-up, death, or until the Sponsor stops the study, whichever comes first.
Study NCT05221502 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Delamanid + Bedaquiline + OPC-167832 10 mg
Description: Delamanid (300 mg once daily \[QD\]) + Bedaquiline (400 mg QD x 2 weeks, then 200 mg thrice-weekly \[TIW\]) + OPC-167832 (10 mg QD) for 17 weeks
Study NCT05221502 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Delamanid + Bedaquiline + OPC-167832 30 mg
Description: Delamanid (300 mg once daily \[QD\]) + Bedaquiline (400 mg QD x 2 weeks, then 200 mg thrice-weekly \[TIW\]) + OPC-167832 (30 mg QD) for 17 weeks
Study NCT05221502 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Delamanid + Bedaquiline + OPC-167832 90 mg
Description: Delamanid (300 mg QD) + Bedaquiline (400 mg QD x 2 weeks, then 200 mg TIW) + OPC-167832 (90 mg QD) for 17 weeks
Study NCT05221502 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: RHEZ
Description: RHEZ for 8 weeks followed by 18 weeks of rifampin and isoniazid (for a total of 26 weeks)
Study NCT04645277 — intervention group
Intervention type: DEVICE
Intervention: Scanning with magnetic resonance imaging
Description: Facial nerves and adjacent blood vessels are scanned using MRI in the patients with hemifacial spasm (HFS). Then multiplanar reconstruction (two dimensional), along with curved planar reconstruction and magnetic resonance virtual endoscopy (three dimensional), will be performed in the different groups of HFS.
Study NCT06059131 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: KeenMind
Description: 320 mg/d (2 capsules/d) during 3 months
Study NCT06059131 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 320 mg/d (2 capsules/d) during 3 months
Study NCT06257602 — intervention group
Intervention type: PROCEDURE
Intervention: Tragal graft tympanoplasty
Description: Comparison study between Endoscopic and microscopic tympanoplasty using tragal graft
Study NCT04409639 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cobimetinib
Description: Cobimetinib is taken on a 28-day cycle. Each dose consists of three 20 mg tablets (60 mg) and should be taken once daily for 21 consecutive days (Days 1 to 21-treatment period); followed by a 7-day break (Days 22 to 28-treatment break). Each subsequent cobimetinib treatment cycle should start after a 7-day treatment break has elapsed.
Study NCT06069440 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Swimming Fatigue Task
Description: Swim freestyle at a steady, controlled pace until mechanical failure (i.e., inability to maintain the predetermined speed) is reached.
Study NCT04644315 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Alectinib
Description: Participants will receive 600 mg oral alectinib BID until disease progression, unacceptable toxicity, withdrawal from treatment, or death.
Study NCT04994470 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Two-week web-based self-help intervention based on principles of positive psychology
Description: The web-based self-help intervention consists of 14 exercises based on the following positive psychology domains: personal strengths, pleasure, gratitude, engagement (flow, mindfulness) and positive relationships.~The (partly interactive) exercises are created to be implemented by the participants themselves without support of a therapist.~Before starting the intervention, the participants are told that they will receive a daily email with an instruction for a short exercise over the period of two weeks. The participants are instructed to complete the exercises every day and are told that they will be asked to evaluate these exercises at the next appointment (post-test, week 2).
Study NCT04994470 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Two-week web-based text messages containing fun facts
Description: The web-based sham comparator consists of 14 text messages containing random interesting facts (fun facts).~Before starting the sham comparator, the participants are told that they will receive a daily email with a text message to read every over the period of two weeks. The participants are instructed to read these text messages every day and are told that they will be asked to evaluate these exercises at the next appointment (post-test, week 2).
Study NCT05416554 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Neuropsychological testing
Description: Upon completion of the consent, the subject will be booked into an available 90 minute in-person or remote neuropsychological testing
Study NCT06034990 — intervention group
Intervention type: OTHER
Intervention: 10-min online survey
Description: This is a cross-sectional study. The data are collected by a 10-min online survey administered to included physicians which will be distributed via online channels such as such as official website or Facebook pages of Society of intensive care or Society of nephrology of corresponding countries.
Study NCT06147024 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: historical control
Description: Received a conventional preoperative assessment
Study NCT06147024 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 3D printed lesion model
Description: Received 3D printed lesion models for preoperative planning
Study NCT05619965 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: sedative
Description: dexmedetomidine 1 mic/kg IV over 10 minutes then 0.4 mic/kg/h continuous IV infusion
Study NCT05619965 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Awake endotracheal intubation by Glidescope videolaryngoscope
Description: Awake endotracheal intubation by Glidescope videolaryngoscope of cervical trauma patient
Study NCT05619965 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Awake endotracheal intubation by Fiberoptic bronchoscope
Description: Awake endotracheal intubation by Fiberoptic bronchoscope of cervical trauma patient
Study NCT04852640 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Active Rehabilitation Program (ARP)
Description: The ARP intervention consists of therapeutic exercises designed to increase shoulder strength and endurance using a cluster of common exercises used for the treatment of shoulder pain. Specifically, the ARP program will focus on increasing scapular motor-control through a phasic program of common therapeutic exercises. This concept has been shown in the literature as capable of reducing shoulder pain and improving function in a variety of pathological conditions, however, the effect of this approach to reducing pain and increasing function for symptomatic shoulder instability is unknown. The selection of exercises and application for each exercise included in the ARP is based on recommendations from the literature and will incorporate participant feedback to customize dosages.
Study NCT04852640 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Nonspecific Passive Intervention (NPI)
Description: The NPI intervention consists of a non-specific treatment approach to shoulder pain that is commonly administered in the clinical setting. Specifically, passive modalities such as ultrasound, massage, and sensory electric stimulation are commonly prescribed in the treatment of shoulder pain to modulate pain. Further, general core strengthening exercises are often implemented. Therefore, the NPI will consist of regularly prescribed passive treatments and general core strengthening exercises, as commonly administered in routine treatment of shoulder pain.
Study NCT05331911 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Propofol
Description: total intravenous anesthesia with propofol for the partial hepatectomy of hepatocellular carcinoma.
Study NCT05767567 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Brief Check Your Drinking (CYD)
Description: The CYD is a brief online intervention designed to provide personalized normative feedback aimed at motivating reductions in drinking
Study NCT05331911 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Description: The sevoflurane group was maintained via sevoflurane vaporizer between 1% and 3% (target minimum alveolar concentration of 0.7-1.3 MAC).
Study NCT05974462 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methylprednisolone 125 MG
Description: 125 mg daily for 3 days diluted in saline solution 250 mL
Study NCT05974462 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: IV saline solution 0.9%
Description: Saline solution 0.9% 250 mL
Study NCT06492655 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: CKD-383(Fed)
Description: After maintaining NPO for at least 10 hours before a high-fat meal, take a high-fat meal within 20 minutes on each medication day, and take CKD-383 two tablets orally with 150 mL of water at room temperature.
Study NCT06492655 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: CKD-383(Fasted)
Description: After maintaining NPO for at least 10 hours before dosing, and take CKD-383 two tablets orally with 150 mL of room temperature water with 30g of sugar added on each dosing day.
Study NCT06097390 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Semaglutide
Description: Oral administration
Study NCT06260514 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: APR-1051
Description: WEE1 Inhibitor
Study NCT05495048 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: NOSES VIIIA
Description: totally laparoscopic right hemicolectomy with transvaginal natural orifice specimen extraction
Study NCT05495048 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: laparoscopic surgery with mini-laparotomy
Description: laparoscopic right hemicolectomy with trans-abdominal extraction from a mini-laparotomy
Study NCT04856592 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Boston Scientific Vici® Venous Stent System
Description: The Vici Venous Stent System comprises two components: the implantable endoprosthesis and its stent delivery system, a 9F over-the-wire system available in a 100cm length and compatible with 0.035in (0.89mm) guidewires
Study NCT04856592 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Boston Scientific Opticross 35 Peripheral Imaging Catheter (OC35 catheter)
Description: The Opticross 35 catheter is designed for use with a guidewire measuring ≤0.035 in (0.89 mm) in diameter and an introducer sheath of 8F (2.67 mm) or larger. The working length of OC35 catheter is 105 cm.
Study NCT05753579 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Spinal Mobilization
Description: Mobilization applications are passive movements that do not involve pushing or stimuli, applied within the range of motion or up to the physiological range of motion.
Study NCT05753579 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Stabilization Exercise
Description: Diyafragmatik solunum ile kombine edilen, pasif-aktif kas iskelet sistemi ve nöral sistemi aktive eden bir yaklaşımdır. Bu yaklaşımda derin çekirdek kaslar olarak transversus abdominis, multifudus kasları aktive edilmektedir
Study NCT05753579 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Stabilization Exercise
Description: Diyafragmatik solunum ile kombine edilen, pasif-aktif kas iskelet sistemi ve nöral sistemi aktive eden bir yaklaşımdır. Bu yaklaşımda derin çekirdek kaslar olarak transversus abdominis, multifudus kasları aktive edilmektedir
Study NCT05377697 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dry lavender flower scent
Description: Participants in the experimental group will be informed about the effects of lavender scent on sleep and lavender sachets will be given. They will be informed that they should put these lavender sachets in their pillows every day and sleep with a lavender sachet for the next month, and that they should not make any changes in their rooms or beds other than the lavender sachet.
Study NCT05028621 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Genetic testing
Description: Genetic testing of blood or tissue sample and limited medical information sent to an outside company. Database will link genome sequence data with human trait information, including cancer and other diseases, to be sent to participant's physician.
Study NCT04026984 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rifamycin SV-MMX
Description: 2 Rifamycin SV-MMX® 50 mg tablets b.i.d. plus ORT
Study NCT04026984 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching Placebo tablets